-
公开(公告)号:US20230081291A1
公开(公告)日:2023-03-16
申请号:US17446951
申请日:2021-09-03
Inventor: Jian QIU , Qi WEI , Matt TSCHANTZ , Heping SHI , Youtong WU , Huiling TAN , Lijun SUN , Chuo CHEN , Zhijian CHEN
IPC: C07D401/14 , C07D401/04 , C07D413/14 , C07D403/04 , C07D409/14 , C07D417/14 , C07D471/08 , C07D405/14 , C07F9/6506 , C07F9/6503 , C07D215/38 , C07D215/42 , C07D215/46 , C07D491/048
Abstract: The present disclosure provides compounds that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
-
公开(公告)号:US20220105198A1
公开(公告)日:2022-04-07
申请号:US17553624
申请日:2021-12-16
Inventor: Zhijian CHEN , Heping SHI , Qi WEI , Chuo CHEN , Lijun SUN , Jian QIU , Youtong WU
Abstract: The present disclosure relates to, among other things, antibody-drug conjugates comprising a STING agonist cyclic di-nucleotide conjugated to an antibody, preparation methods therefor, and uses therefor.
-
公开(公告)号:US20200308216A1
公开(公告)日:2020-10-01
申请号:US16903173
申请日:2020-06-16
Inventor: Zhijian CHEN , Lijun SUN , Jiaxi WU , Heping SHI , Chuo CHEN
IPC: C07H21/02 , A61K39/39 , C12Q1/6876 , C12Q1/25 , G01N33/573 , A61K31/7084 , G01N33/564
Abstract: Cyclic-GMP-AMP synthase (cGAS) and cyclic-GMP-AMP (cGAMP), including 2′3-cGAMP, 2′2-cGAMP, 3′2′-cGAMP and 3′3′-GAMP, are used in pharmaceutical formulations (including vaccine adjuvants), drug screens, therapies, and diagnostics.
-
公开(公告)号:US20200010501A1
公开(公告)日:2020-01-09
申请号:US16438153
申请日:2019-06-11
Inventor: Boyu ZHONG , Heping SHI , Yuanwei DAI , Qi WEI , Chuo CHEN , Zhijian CHEN , Lijun SUN
IPC: C07H21/02 , C07H21/04 , A61K31/7084 , A61K45/06
Abstract: Disclosed are cyclic-di-nucleotide cGAMP analogs, methods of synthesizing the compounds, pharmaceutical compositions comprising the compounds thereof, and use of compounds and compositions in medical therapy.
-
公开(公告)号:US20240092760A1
公开(公告)日:2024-03-21
申请号:US18334325
申请日:2023-06-13
Inventor: Jian QIU , Qi WEI , Matt TSCHANTZ , Heping SHI , Youtong WU , Huiling TAN , Lijun SUN , Chuo CHEN , Zhijian CHEN
IPC: C07D401/14 , C07D215/38 , C07D215/42 , C07D215/46 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D491/048 , C07F9/6503 , C07F9/6506
CPC classification number: C07D401/14 , C07D215/38 , C07D215/42 , C07D215/46 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D491/048 , C07F9/65031 , C07F9/6506
Abstract: The present disclosure provides compounds that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
-
公开(公告)号:US20230270773A1
公开(公告)日:2023-08-31
申请号:US17768922
申请日:2020-10-14
Inventor: Zhijian CHEN , Lijun SUN
IPC: A61K31/708 , C07K16/28 , A61P35/00
CPC classification number: A61K31/708 , A61P35/00 , C07K16/2818 , C07K16/2827
Abstract: The disclosure provides methods of treating a cancer in a patient by administering a compound (“Compound A”) having the following structure or a pharmaceutically acceptable salt thereof: at particular dosing regimens and, optionally, in combination with one or more compounds that inhibit immune checkpoint proteins.
-
公开(公告)号:US20220356158A1
公开(公告)日:2022-11-10
申请号:US17191305
申请日:2021-03-03
Inventor: Boyu ZHONG , Lijun SUN , Heping SHI , Jing LI , Chuo CHEN , Zhijian CHEN
IPC: C07D277/34 , C07D417/14 , A61K31/429 , A61K31/4365 , A61K31/4439 , A61K31/506 , A61K31/519 , A61K31/427 , C07D277/40 , A61K31/437 , A61K31/426 , A61K31/381 , A61K31/433 , A61K31/4709 , A61K39/39 , A61K45/06 , A61K31/454 , A61K31/4725 , A61K31/497 , A61K31/4985 , A61K31/501 , C07D277/36 , C07D403/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D471/04 , C07D495/04 , C07D513/04
Abstract: Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
-
公开(公告)号:US20210290774A1
公开(公告)日:2021-09-23
申请号:US17317864
申请日:2021-05-11
Inventor: Zhijian CHEN , Heping SHI , Qi WEI , Chuo CHEN , Lijun SUN , Jian QIU , Youtong WU
Abstract: The present disclosure relates to, among other things, antibody-drug conjugates comprising a STING agonist cyclic di-nucleotide conjugated to an antibody, preparation methods therefor, and uses therefor.
-
-
-
-
-
-
-